Skip to content

Circles

M

Myriad Genetics Inc

MYGN· Nasdaq

M

MYGNMyriad Genetics Inc

MYGNMyriad Genetics Inc·Earnings record

Q2 2010

Source filing unavailable

Previous · Q1 2010 Next · Q3 2010

Q2 2010 · —

Revenue

$92.77M

no prior Q2 2009 on file

Net Income

$35.36M

no prior Q2 2009 on file

EPS Diluted

$0.36

no prior Q2 2009 on file

Operating Income$34,522,000—

Operating Cash Flowderived$42,727,000—

Same quarter

no prior Q2 2009 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Filing lag

Quarterly history

Q1 ’10Q2 ’10Q3 ’10 Q4 ’10^d Q1 ’11 Q2 ’11 Q3 ’11 Q4 ’11^d Q1 ’12…

Myriad Genetics Inc · CIK 899923 · Engraved from SEC EDGAR

Free Cash Flowderived

$38,384,000—

Margins · derived

Operating margin37.2%

Net margin38.1%

Thaler ResearchEngraved from SEC EDGAR© 2026 Thaler. All rights reserved.Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Platform

Using AI API SDKs CLI

Research

News Listen Earnings Insiders Holders Compare Metrics

Screener Watchlists Pies Notes Your companies

Learn

Thaler

Thaler Agent Promise Provenance Circles Account Terms Privacy